Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

38.45
Delayed Data
As of Aug 25
 -0.22 / -0.57%
Today’s Change
37.41
Today|||52-Week Range
51.88
-9.85%
Year-to-Date
Tone-Deaf Mylan Provides Election-Year Fodder
Aug 25 / MotleyFool.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content
Cramer: It's a Presidential Campaign, So Let the Corporate Bashing Begin
Aug 24 / TheStreet.com - Paid Partner Content
What Pfizer Gets in Its $14 Billion Medivation Deal
Aug 23 / MotleyFool.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug 24 / TheStreet.com - Paid Partner Content
Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)
Aug 23 / Zacks.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?
Aug 22 / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised)
Aug 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.67
Today’s open38.67
Day’s range38.37 - 38.75
Volume1,652,336
Average volume (3 months)2,110,775
Market cap$99.5B
Dividend yield4.33%
Data as of 4:02pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.80%
Revenue growth (last year)-14.57%
P/E ratio24.2
Price/Sales2.96
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.17+0.29%
AGNAllergan-6.96-2.86%
ABBVAbbVie-0.34-0.52%
GSKGlaxoSmithKline-0.16-0.36%
Data as of 4:02pm ET, 08/25/2016

Financials

Next reporting dateOctober 29, 2016
EPS forecast (this quarter)$0.86
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts

Partner Offers

Search for Jobs